Analysts Defend Tobacco Names Following FDA's Menthol Report, See Ban as Unlikely

By: Benzinga
Several analysts are defending stocks in the Tobacco group Tuesday following an earlier comment from the FDA that menthol cigarettes likely have a "public health impact." Stocks in the sector are trading lower amid the concern. Altria (NYSE: MO ) shares are down 2.4 percent, Reynolds American (NYSE:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.